HCA Healthcare stock trades at USD 439.00 as BMO sets USD 495.00 target

Published on 09/28/2026 at 16:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

HCA Healthcare stock drew BMO Capital's Outperform rating on September 22, 2026. Q2 revenue reached USD 20.23 billion, up 8.70 percent year over year, while adjusted EPS beat forecasts.

Fotorealistisches Krankenhaus-Außengebäude mit Ambulanzen am Haupteingang bei Sonnenuntergang — HCA Healthcare US40412C1018 zeigt einen modernen Krankenhaus Campus mit Notaufnahme bei goldenem Abendlicht, Illustration mit AI erstellt.

HCA Healthcare stock (ISIN US40412C1018) was trading at USD 439.00 on the NYSE on September 28, 2026 at 10:55 a.m. ET, up 0.78 percent from the prior close. The immediate catalyst is analyst coverage from BMO Capital, which set a USD 495.00 price target on September 22, 2026.

BMO sets a USD 495.00 target

According to Investing.com on September 22, 2026, BMO Capital initiated coverage with an Outperform rating and a USD 495.00 target. That target stands 12.76 percent above the USD 439.00 intraday price, giving the analyst call a clearly defined valuation reference.

The stock's current quote remains below its 52-week high of USD 556.52 and above its 52-week low of USD 353.99. Its market capitalization was USD 95.0 billion on September 28, 2026, while session volume stood at 204,131 shares.

Revenue growth meets guidance pressure

HCA Healthcare's second-quarter 2026 revenue reached USD 20.23 billion, according to Investing.com, an 8.70 percent increase from the same quarter a year earlier. Adjusted earnings per share came to USD 7.59, exceeding the cited USD 7.40 consensus, while revenue also topped the USD 19.38 billion forecast.

The earnings comparison is favorable, but the outlook is less uniform. Investing.com reported that HCA Healthcare lowered its full-year profit guidance after changes in payer mix linked to the expiration of enhanced Affordable Care Act premium subsidies. That factor helps explain why positive quarterly numbers have produced a mixed analyst picture.

Stock stays below its yearly high

HCA Healthcare operates hospitals, ambulatory surgery centers, emergency facilities, physician practices and other healthcare locations in the United States. StockAnalysis identifies the company as a healthcare business listed on the NYSE under ticker HCA, with USD as its reporting currency.

For investors, the key tension is visible in the figures: second-quarter revenue grew 8.70 percent year over year, yet payer mix and guidance remain central to the valuation debate. The USD 495.00 BMO target therefore sits against both operating growth and a lower profit outlook.

HCA stock trades at USD 439.00

HCA Healthcare stock was last at USD 439.00 on the NYSE on September 28, 2026 at 10:55 a.m. ET. The session range was USD 431.16 to USD 443.14, with a market capitalization of USD 95.0 billion.